title: MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells.
abstract: MicroRNA signatures of BAL cells and alveolar macrophages are currently lacking in IPF. Here we sought to investigate the expression of fibrosis-related microRNAs in the cellular component of the BAL in IPF. We thus focused on microRNAs previously associated with fibrosis (miR-29a, miR-29b, miR-29c, let-7d, and miR-21) and rapid IPF progression (miR-185, miR-210, miR-302c-3p miR-376c and miR-423-5p). Among the tested microRNAs miR-29a and miR-185 were found significantly downregulated in IPF while miR-302c-3p and miR-376c were not expressed by BAL cells. Importantly, the downregulation of miR-29a inversely correlated with the significantly increased levels of COL1A1 mRNA in IPF BAL cells. Collagen 1 a was found mainly overexpressed in alveolar macrophages and not other cell types of the BAL by immunofluorescence. In view of the downregulation of miR-185, we tested the response of THP-1 macrophages to profibrotic cytokine TGFb and observed the downregulation of miR-185. Conversely, proinflammatory stimulation lead to miR-185 upregulation. Upon examination of the mRNA levels of known miR-185 targets AKT1, DNMT1 and HMGA2, no significant correlations were observed in the BAL cells. However, increased levels of total AKT and AKTser473 phosphorylation were observed in the IPF BAL cells. Furthermore, miR-185 inhibition in THP-1 macrophages resulted in significant increase of AKTser473 phosphorylation. Our study highlights the importance of BAL microRNA signatures in IPF and identifies significant differences in miR-185/AKT and miR-29a/collagen axes in the BAL cells of IPF patients.
authors: Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.|Department of Clinical Laboratory Medicine, Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, Crete, Greece.
authors: Eliza
authors: E
authors: Tsitoura
authors: Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, SW3 6NP, London, UK.
authors: Athol U
authors: AU
authors: Wells
authors: Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.
authors: Kostantinos
authors: K
authors: Karagiannis
authors: Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.
authors: Ismini
authors: I
authors: Lasithiotaki
authors: Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.|Department of Thoracic Medicine, Interstitial Lung Disease Unit, University Hospital of Heraklion, Heraklion, Crete, Greece.
authors: Eirini
authors: E
authors: Vasarmidi
authors: Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.|Department of Thoracic Medicine, Interstitial Lung Disease Unit, University Hospital of Heraklion, Heraklion, Crete, Greece.
authors: Eleni
authors: E
authors: Bibaki
authors: Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.
authors: Chara
authors: C
authors: Koutoulaki
authors: Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, SW3 6NP, London, UK.
authors: Hiroe
authors: H
authors: Sato
authors: Department of Clinical Laboratory Medicine, Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, Crete, Greece.
authors: Demetrios A
authors: DA
authors: Spandidos
authors: Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.
authors: Nikolaos M
authors: NM
authors: Siafakas
authors: Department of Clinical Laboratory Medicine, Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, Crete, Greece.
authors: George
authors: G
authors: Sourvinos
authors: Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.|Department of Thoracic Medicine, Interstitial Lung Disease Unit, University Hospital of Heraklion, Heraklion, Crete, Greece.
authors: Katerina M
authors: KM
authors: Antoniou
mesh_terms: D000368:Aged; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002460:Cell Line; D024042:Collagen Type I / Q000235:genetics* / Q000378:metabolism; D005260:Female; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D007958:Leukocyte Count; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism; D008297:Male; D035683:MicroRNAs / Q000235:genetics*; D008875:Middle Aged; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics* / Q000378:metabolism; D034622:RNA Interference; D012129:Respiratory Function Tests; D012307:Risk Factors; D015398:Signal Transduction; D053773:Transforming Growth Factor beta1 / Q000494:pharmacology
chemical_list: D024042:Collagen Type I; C552431:MIRN185 microRNA, human; C532045:MIRN29a microRNA, human; D035683:MicroRNAs; D053773:Transforming Growth Factor beta1; D051057:Proto-Oncogene Proteins c-akt
keywords: AKT; IPF; Immune response; Immunity; Immunology and Microbiology Section; bronchoalveolar lavage fluid; collagen; microRNA